We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Phillips 66
PSX
$84.9B
| $182K | 0.01% |
+2,606
| New | +$153K |
|
52
Philip Morris
PM
$297B
| $180K | 0.01% |
+2,173
| New | +$169K |
|
|
CTLT
53
DELISTED
CATALENT, INC.
CTLT
| $180K | 0.01% |
+1,729
| New | +$168K |
|
54
Jacobs Solutions
J
$15.9B
| $178K | 0.01% |
+1,979
| New | +$168K |
|
55
L3Harris
LHX
$51.6B
| $178K | 0.01% |
+944
| New | +$173K |
|
56
Quanta Services
PWR
$100B
| $178K | 0.01% |
+2,465
| New | +$163K |
|
57
Apple
AAPL
$4.54T
| $177K | 0.01% |
+1,336
| New | +$161K |
|
58
Altria Group
MO
$114B
| $176K | 0.01% |
+4,293
| New | +$172K |
|
59
Synopsys
SNPS
$74.4B
| $176K | 0.01% |
+677
| New | +$156K |
|
60
Marathon Petroleum
MPC
$92.4B
| $174K | 0.01% |
+4,205
| New | +$151K |
|
|
ATVI
61
DELISTED
Activision Blizzard
ATVI
| $174K | 0.01% |
+1,878
| New | +$153K |
|
62
Skyworks Solutions
SWKS
$9.37B
| $173K | 0.01% |
+1,130
| New | +$165K |
|
63
Valero Energy
VLO
$92.9B
| $173K | 0.01% |
+3,054
| New | +$150K |
|
64
Take-Two Interactive
TTWO
$45.4B
| $171K | 0.01% |
+825
| New | +$144K |
|
|
DFS
65
DELISTED
Discover Financial Services
DFS
| $170K | 0.01% |
+1,879
| New | +$140K |
|
66
HF Sinclair
DINO
$16.5B
| $170K | 0.01% |
+6,563
| New | +$149K |
|
67
Johnson & Johnson
JNJ
$618B
| $170K | 0.01% |
+1,080
| New | +$159K |
|
68
Synchrony
SYF
$24.7B
| $169K | 0.01% |
+4,856
| New | +$146K |
|
69
Abbott
ABT
$183B
| $168K | 0.01% |
+1,536
| New | +$167K |
|
70
Capital One
COF
$128B
| $168K | 0.01% |
+1,698
| New | +$144K |
|
71
Digital Realty Trust
DLR
$69.7B
| $168K | 0.01% |
+1,202
| New | +$172K |
|
72
Freeport-McMoran
FCX
$90B
| $167K | 0.01% |
+6,399
| New | +$133K |
|
|
MXIM
73
DELISTED
Maxim Integrated Products
MXIM
| $167K | 0.01% |
+1,879
| New | +$148K |
|
74
Electronic Arts
EA
$53B
| $166K | 0.01% |
+1,159
| New | +$149K |
|
75
Motorola Solutions
MSI
$72.3B
| $166K | 0.01% |
+975
| New | +$164K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.